R&D-INSECT & DIS CONT-A RES/EXPL DE

右

• 批准号: 8334113
• 负责人: SANFORD GARNER
• 金额: $ 130.37万
• 依托单位: INTEGRATED LABORATORY SYSTEMS, LLC
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-11-22 至 2015-11-21
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8334113
• 关键词: Address; Animals; Biological; Biology; Carcinogens; Chemicals; Contractor; Contracts; Educational workshop; Epidemiology; Government; Human; Individual; Insecta; Malignant Neoplasms; National Toxicology Program; Participant; Peer Review; Preparation; Process; Property; Public Health; Published Comment; Publishing; Reporting; Toxicogenetics; United States Dept. of Health and Human Services; United States Public Health Service; Writing; cancer risk; carcinogenicity; exposed human population; genotoxicity; indexing; meetings; member; research and development

The Report on Carcinogens (RoC) is a scientific and public health document that identifies substances that may put people at increased risk for cancer. It is a congressionally [section 301 (b) (4) of the Public Health Service Act] mandated document prepared by the National Toxicology Program (NTP) for the Secretary of the U.S. Department of Health and Human Services. Substances considered by the NTP for possible listing or delisting in the RoC are evaluated by a rigorous scientific review process, which includes external and government scientific input, opportunity for public comment, and external peer review. Substances are listed in the RoC as either known or reasonably anticipated to be a human carcinogen. The current contract was established to provide support for the preparation of scientific documents, convening review meetings, and for the preparation of the final RoC. These projects require that the Contract staff be composed of individuals with expertise in different scientific disciples (toxicology, genetic toxicology, biology, exposure assessment, and epidemiology).

《致癌物报告》（RoC）是一份科学和公共卫生文件，确定了可能增加人们患癌症风险的物质。这是一份国会[《公共卫生服务法》第301（B）（4）条]授权的文件，由国家毒理学计划（NTP）为美国卫生与公众服务部部长编写。NTP考虑在RoC中可能列名或除名的物质通过严格的科学审查程序进行评估，其中包括外部和政府科学投入，公众评论的机会和外部同行审查。在RoC中列出的物质是已知或合理预期的人类致癌物。 目前的合同是为了支持科学文件的编写、召开审查会议和最终RoC的编写而订立的。这些项目要求合同工作人员由具有不同科学学科（毒理学、遗传毒理学、生物学、接触评估和流行病学）专业知识的个人组成。